International forum of allergy & rhinology · 2026
Using Local sIgE Threshold to Refine the Diagnosis of Local Allergic Rhinitis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Zengxiao, Zhang Xu, Li Jingyun, Song Yu, Xi Lin, Zhang Yu, Zhang Luo, Zhang Yuan
Аннотация
BACKGROUND: Local allergic rhinitis (LAR) is a chronic rhinitis (CR) phenotype with localized IgE production but no systemic atopy. Diagnosis relies on the nasal allergen challenge (NAC), but its correlation with the underlying immunological endotype is unclear, necessitating a more reliable biomarker. Therefore, this study was conducted to evaluate a local specific immunoglobulin E (sIgE) threshold for diagnosing house dust mite (HDM)-sensitized LAR and compare its immunological relevance to the conventional NAC-based method.
METHODS: This prospective study enrolled 181 CR patients without systemic atopy and 146 healthy controls. All CR patients underwent NAC. Local sIgE levels of Dermatophagoides pteronyssinus and Dermatophagoides farinae were measured in nasal secretions. A diagnostic threshold was established using the 95th percentile from the healthy cohort. The NAC and sIgE-based stratifications were then compared by analyzing patients' nasal cytokine profiles.
RESULTS: Classification based on NAC positivity did not reveal significant differences in local sIgE or a consistent type 2 inflammatory signature. In contrast, stratification using the established local sIgE threshold (≥ 0.14 kUA/L) identified a local sIgE-high group with significantly elevated levels of type 2 cytokines (IL-4, IL-5, CCL5, and CCL11) compared to the sIgE-low group (all p < 0.05). Furthermore, local sIgE levels positively correlated with these type 2 cytokines in the sIgE-high group.
CONCLUSION: A local sIgE threshold reliably identifies an immunologically distinct LAR endotype, aligning diagnosis with its type 2 pathophysiology. This biomarker-driven approach offers a precise tool to refine diagnostic algorithms and improve patient selection for targeted therapies.
METHODS: This prospective study enrolled 181 CR patients without systemic atopy and 146 healthy controls. All CR patients underwent NAC. Local sIgE levels of Dermatophagoides pteronyssinus and Dermatophagoides farinae were measured in nasal secretions. A diagnostic threshold was established using the 95th percentile from the healthy cohort. The NAC and sIgE-based stratifications were then compared by analyzing patients' nasal cytokine profiles.
RESULTS: Classification based on NAC positivity did not reveal significant differences in local sIgE or a consistent type 2 inflammatory signature. In contrast, stratification using the established local sIgE threshold (≥ 0.14 kUA/L) identified a local sIgE-high group with significantly elevated levels of type 2 cytokines (IL-4, IL-5, CCL5, and CCL11) compared to the sIgE-low group (all p < 0.05). Furthermore, local sIgE levels positively correlated with these type 2 cytokines in the sIgE-high group.
CONCLUSION: A local sIgE threshold reliably identifies an immunologically distinct LAR endotype, aligning diagnosis with its type 2 pathophysiology. This biomarker-driven approach offers a precise tool to refine diagnostic algorithms and improve patient selection for targeted therapies.